Dr James Campbell is the CEO of Patrys Limited, an ASX-listed biotech company developing novel antibody therapeutics for cancer. As a senior biotechnology executive, Dr Campbell’s successful career in biotech includes bench research, academic technology transfer, establishment of early-stage start-ups, leading private and public companies, and being involved in hundred million-dollar deals. With more than 25 years’ experience in research, research management, consulting and venture capital in Australia and internationally, Dr Campbell has a unique set of skills that enable him to identify and monetise future trends in the biotech and pharmaceutical industries.